bpc 157 human clinical trial dosing bpc-157 protocol BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 (5mg Vial) Dosage Protocol
Description
Clinical Update 7/27/2021 Diets for Fatty Liver Disease Are some diets more beneficial than others for fatty liver disease
[DOI] [PubMed] [Google Scholar] Bckmann R
It is also important for releasing energy from food and using vitamin B11 (folic acid)
Peptides may be one part of that plan for some people
Its mostly used in research settings
This overlap with the mTOR axis places MOTS-c in an interesting relationship with The Rapamycin Protocol, the most direct pharmaceutical intervention on the mTOR pathway
